IMODIUM A-D CAPLETS OTC
Generic Name and Formulations:
McNeil Consumer Healthcare
Indications for IMODIUM A-D CAPLETS:
Acute: Initially 4mg, then 2mg after each loose stool; max 16mg/day. Stop after 48 hours if ineffective. Chronic: initially 4mg; maintenance 4–8mg/day. Reevaluate if no improvement after 10 days at 16mg/day.
<2yrs: not recommended. 24–47lbs (2–5yrs): 1mg up to 3 times daily for 2 days (use liq). 48–59lbs (6–8yrs): initially 2mg, then 1mg after each loose stool; max 4mg/day for 2 days. 60–95lbs (9–11yrs): initially 2mg, then 1mg after each loose stool; max 6mg/day for 2 days.
If constipation must be avoided. Acute dysentery.
Acute ulcerative colitis and antibiotic induced pseudomembranous colitis; discontinue if abdominal distention occurs. In dehydration, use fluid and electrolyte replacement. Hepatic dysfunction; monitor for CNS toxicity. Pregnancy (Cat.B). Nursing mothers.
Abdominal pain, distention, constipation, dry mouth, nausea, drowsiness, dizziness, fatigue, rash.
Caps—30; A-D Caplets—6, 12, 18, 24; A-D Liq—2oz, 4oz; Multi-Symptom Caplets—12, 42; Multi-Symptom Chew tabs—18, 42
Neurology Advisor Articles
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Significant Variations in Epilepsy Surgical Strategy, Deficit Reporting Exist
- Smoking Promotes Disease Progression in Multiple Sclerosis
- Situation Framing, Language Can Influence Decision-Making
- Thrombolysis With Tenecteplase Is as Safe as Alteplase in Stroke Mimics
- FDA: Opioid Analgesic REMS Expanded to Include Immediate-Release Products